Drug Information Association Logo
Corporate Tagline
15th European Conference on EDM

Call for Abstracts

Submit an Abstract Now!

Submit an Abstract for the 15th edition of the Conference on European Electronic Document Management - the focus point this year is Standardisation - Blessing or Curse? Submit Abstracts by 21 May 2014.

Learn More
ECRD Berlin

Keynote by German Health Minister!

The European Conference on Rare Diseases & Orphan Products (ECRD) is the unique platform/forum across all rare diseases, across all European countries, bringing together all stakeholders. New insights especially for industry participants will be shared in two dedicated industry themes.

Learn More

Access Presentations!

Attendees: Presentations from the EuroMeeting are now available.

Learn More
EuroMeeting 2015

Call for Abstracts Now Open!

Submit an abstract for the EuroMeeting 2015 in Paris. The call for abstracts is open until 4 June 2014.

Learn More
Clinical Forum 2015

Call for Abstracts

Submit an abstract for the Clinical Forum 2015 in Paris. The themes at this conference will be Clinical Operations, Technical Operations, Peri-Approval Research, and Medical writing. Find out more here!

Learn More

GO From the Editor's Desk

What Lies AheadWhat Lies Ahead for 2014?

DIA's second annual What Lies Ahead? report, provides expert insight into the year ahead for pharmaceuticals, biotechnology, and the product development of medical devices.

Read report


Breaking News
TOP NEWS

DIA Making News from 26th Annual EuroMeeting

Pharma 'missing an opportunity with remote monitoring technologies'

Read report

Absence of Good Practices a Flaw in Global Drug Harmonization Activities

Read report

Orphan Drug Talks & Midnight Meetings Under Japan-EMA Collaborations

Read report

EU Pediatric Rules are Top Regulatory Headache for Drug Companies; Variations & Fees Close Behind

Read report

DIA Launches New TIRS Blog

DIA’s journal, Therapeutic Innovation & Regulatory Science, has launched a new blog, titled “Collaborate to Innovate.” The blog aims to further public conversation about global therapeutic advances and regulatory policies by offering expert insight on current trends and fresh perspectives on timely industry news. Read the blog. Don’t forget to follow the blog to stay current on new entries.

The blog is just another facet of TIRS’ multimedia approach to industry news. We also offer monthly podcasts, featuring commentary by industry experts. They are available on the blog. Listen to Podcasts.

Both the blog and our podcasts are complimentary to all site visitors, so please share them with your professional network.

     

Barbara Lopez-Kunz


Read Global Chief Executive Barbara Lopez Kunz's March Message

 


DIANew! Content Currents

DIA's Content Currents provides important new global regulatory developments and their impact on pharmaceutical, biotechnology, and medical product development.

Read current issue. 


SCRIP100.comNew! DIA Europe and Director Jytte Lyngvig were spotlighted in SCRIP100.com.

Read their profile "A Forum for Future Leaders."

Global ForumApril 2014 Global Forum Now Online: The US National Institutes of Health estimates that there are approximately 6,000 rare diseases affecting 25 million Americans. EURORDIS, the Voice of Rare Disease Patients in Europe, estimates the number of persons in Europe suffering from a rare disease at over 30 million. This Special Section Orphan Drugs in the 21st Century explores different strategies and pathways to meet the needs of patients around the world with rare diseases, including an interview with the Director of the FDA Office of Orphan Product Development. Also Featured: Our interview with DIA 2014 50th Annual Meeting Keynote Speaker Jamie Heywood, and previews of our 6th Latin American Regulatory Conference: LARC 2014 and our 8th Annual Conference in Japan for Asian New Drug Development.

Read the April issue.

TIRSGuest Commentary: Therapeutic Innovation & Regulatory Science - March 2014

Steven P Spielberg MD, PhD Discusses the Evolution of Therapeutic Interventions that have Stemmed from the AIDS Epidemic

 

Read full commentary.

Read more TIRS articles.

NEW! Read our blog.

GO DIA 2014 50th Annual Meeting

DIA 2014 50th Annual Meeting: Celebrate the Past - Invent the Future

June 15-19 | San Diego, CA

This year marks the 50th Anniversary of the DIA Annual Meeting, the largest multidisciplinary event that brings together a global network of life sciences professionals to foster innovation that will lead to the development of safe and effective medical products and therapies to patients. With this year’s theme, Celebrate the Past - Invent the Future, we will be doing just that and DIA invites YOU to join us in San Diego. Register Early to Save!

The DIA Annual Meeting is the best opportunity to meet with people from around the world, share your views and knowledge, network, and build new relationships.

Schedule At-A-Glance | Overview | Register Now | Justification Letter

View the Continuing Education credits that are available.


Search more than 260 educational offerings over 21 tracks on today’s hottest topics!


Search by country/region on today’s hottest topics too!


HeywoodThis year’s Keynote Speaker!

Jamie Heywood
Co-Founder and Chairman, PatientsLikeMe
Founding Director, ALS Therapy Development Institute

Monday, June 16 | 2:30PM PT

GO Meetings & Training

Europe-Calendar  


Upcoming educational opportunities in your region:

Plan this year's professional development
for yourself and your team in the following areas:

  • Regulatory Affairs
  • Clinical Research
  • Non-clinical Safety
  • Pharmacovigilance
  • EudraVigilance

DIA Europe's training calendar is updated regularly, remember to check back for additions or changes from time to time.

Keep an overview of dates for conferences and training courses, so you can mark your calendar well in advance.

Search for training courses online

eLearning CatalogeLearning Catalog

Read

GO Member Benefits

MembershipNew! Free access to one of DIA's archived webinars featuring up-to-the-minute information about the latest developments in the medical product industry

Just added! The Impact of Drug Shortages on the Pharmaceutical Industry

More than 18,000 members worldwide look to DIA as the only global, neutral, nonprofit, multidisciplinary association to address the challenges you face every day. Take advantage of all the benefits of membership, including:

DIA ConneXDIA ConneX is a trusted, interactive, web-based network that links DIA’s 18,000-member global community. DIA members use ConneX to collaborate, communicate, network, and exchange information. Through ConneX, DIA members:

  • Share documents
  • Engage in online discussions
  • Post community event information
  • Make announcements and post news
  • Join Communities (formerly SIACs)

 

GO Exhibiting & Advertising

Showcase your company's products or services to key decision-makers from across the pharmaceutical, biotechnology, medical device, and related fields.

Contract Service OrganizationsContract Service Organization (CSO) Directory 

Reserve your spot in our exclusive print and online partner directory featuring full-page descriptions and contact information for yours and other clinical trial and medical product development service companies around the world.

View partner listings.

 


Exhibiting Opportunities

Join DIA and an anticipated 450+ companies with a booth at the DIA 2014 50th Annual Meeting! 

Upcoming exhibiting opportunities in your region:

Drug Information Journal

Advertise your company's products and services to professionals from the pharmaceutical, biotechnology, medical device, and related sectors.

Advertise
Global Forum

Place your advertising message in front of more than 18,000 professionals involved in every aspect of medical product discovery, development, and delivery.

Advertise

GO Communities Showcase

Membership

New Era for Communities

DIA is a global member association that provides knowledge resources across the full spectrum of medical product development. In the last few years the organization has expanded that global reach and will continue to grow to meet the need for health care knowledge exchange around the world.

As DIA’s reach expands globally we believe a name change is necessary. Our global volunteers came to consensus on "Community" to replace "SIACs." This change will enhance the visibility of the groups and make it much easier to recognize their purpose.

Each Community is led by a chairperson who is responsible for the overall activities of the Community. View complete list of Community chairpersons.

GO Student Initiatives

DIA offers students many opportunities to get involved and contribute in a collegial, inclusive, collaborative, positive, respectful, and professional environment in support of DIA’s mission. available student opportunities include:

  • Student Volunteer Program
  • Young Professionals Fellowship Program
  • Student Fellowship Program
  • Complimentary EuroMeeting registration
  • Student Poster Session (North America, Europe, China Annual Meetings)
  • Discount registration (North America and Europe Annual Meetings)
  • Group Discounts for DIA Student Chapter members
  • Student Membership
  • Student Engagement at DIA Annual Meeting
  • Student Chapters

Featured Story

Breaking NewsMedical Students Remain Unfazed by Professors Industry Relationships

Read article.

 

Featured Video

Medical Genetics Residency Programs: Medical Genetics is Transforming Medicine

GO Patient Initiatives

Through DIA’s worldwide conferences and programs, patient representatives have opportunities to develop, strengthen, and support collaborations with policymakers, health professionals, industry representatives, and academia while promoting dialogue and sharing best practices.

Birth Defects: Common, Costly, Critical

Produced and directed by Utah parents of children with birth defects in collaboration with the National Birth Defects Prevention Network.

 

 

 

 

The EuroMeeting Patient Fellowship Program is designed to:

Develop, strengthen, and support patient collaborations with policy makers, health professionals, industry representatives, and academia;

Increase the knowledge and understanding of patient groups about key issues central to patient-centered healthcare, biomedical research, and drug development;

Develop the capacity of patient groups to advocate for change;

Improve alliances between patient groups and other healthcare stakeholders; and

Stimulate cooperation, promote dialogue, and share best practices.

Training

Learn from the Best - Upcoming Training Courses in Europe

Benefit/Risk Management
19-20 May 2014 | Prague, Czech Republic
This intensive course explores current opportunities made possible by the new legislation, advances in information technology and a new scientific methodology to enhance and modernise the approaches in the product lifecycle management. The entire course has been updated in line with the latest guidelines on EU Good Pharmacovigilance Practices (GVP): Module IX - Signal management, Commission Implementing Regulation (EU) No. 520/2012, and CIOMS VIII.21-22 May 2014 | Prague, Czech Republic

Signal Management in Pharmacovigilance
21-22 May 2014 | Prague, Czech Republic
The entire course has been updated in line with the latest guidelines on EU Good Pharmacovigilance Practices (GVP): Module IX - Signal management, Commission Implementing Regulation (EU) No. 520/2012, and CIOMS VIII.

New Version! Essentials of European Regulatory Affairs
This is the must-attend training course for anyone needing to learn the essentials of European Regulatory Affairs - it has been extended to two days to include more topics, and it is kept up to date in minute detail by the experienced faculty.


EMA Excellence in Pharmacovigilance: Clinical trials and post-marketing 
13-17 October 2014 | London, UK
This course is designed to provide a firm grounding in key aspects of Global Clinical Pre- and Post-Marketing Safety. This five-day training course, presented by the European Medicines Agency, now also includes highlights and updates on the implementation of the new pharmacovigilance legislation and the latest news on the international harmonisation and standardisation activities in pharmacovigilance.
View Training Courses